Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 299, Issue 3, 2010, Pages

  Urboniene, Dalia ^a   Haber, Idith ^a   Fang, Yong Hu ^a   Thenappan, Thenappan ^a   Archer, Stephen L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Inhaled anesthesia; Pulmonary artery acceleration time; Pulmonary hemodynamics; Right ventricular hypertrophy; Rodent models of pulmonary hypertension

Indexed keywords

ISOFLURANE; MONOCROTALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; GOLD STANDARD; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART OUTPUT; HEART RATE; LUNG ARTERY PRESSURE; LUNG CIRCULATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; THERMODILUTION; ANIMAL; BLOOD PRESSURE; CATHETERIZATION; CHEMICALLY INDUCED DISORDER; HEART RIGHT VENTRICLE HYPERTROPHY; HEMODYNAMICS; INSTRUMENTATION; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY ARTERY; SPRAGUE DAWLEY RAT; VALIDATION STUDY;

ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; CATHETERIZATION; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEMODYNAMICS; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MONOCROTALINE; PULMONARY ARTERY; PULMONARY CIRCULATION; RATS; RATS, SPRAGUE-DAWLEY; THERMODILUTION;

EID: 77956713444     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00114.2010     Document Type: Article

References (41)

1. Badea CT, Bucholz E, Hedlund LW, Rockman HA, Johnson GA. Imaging methods for morphological and functional phenotyping of the rodent heart. Toxicol Pathol 34: 111-117, 2006.
2. Bonnet S, Michelakis ED, Porter CJ, Andrade-Navarro MA, Thebaud B, Haromy A, Harry G, Moudgil R, McMurtry MS, Weir EK, Archer SL. An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension. Circulation 113: 2630-2641, 2006.
3. Boxt LM. MR imaging of pulmonary hypertension and right ventricular dysfunction. Magn Reson Imaging Clin N Am 4: 307-325, 1996. (Pubitemid 26153168)
4. Brecker SJ, Gibbs JS, Fox KM, Yacoub MH, Gibson DG. Comparison of Doppler derived haemodynamic variables and simultaneous high fidelity pressure measurements in severe pulmonary hypertension. Br Heart J 72: 384-389, 1994.
5. Dabestani A, Mahan G, Gardin JM, Takenaka K, Burn C, Allfie A, Henry WL. Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol 59: 662-668, 1987.
6. Ferrara KW, Merritt CR, Burns PN, Foster FS, Mattrey RF, Wickline SA. Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents. Acad Radiol 7: 824-839, 2000.
7. Ghofrani HA, Seeger W, Grimminger F. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 353: 1412-1413, 2005. (Pubitemid 41362714)
8. Gomberg-Maitland M, Maitland ML, Barst RJ, Sugeng L, Coslet S, Perrino TJ, Bond L, Lacouture ME, Archer SL, Ratain MJ. A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension. Clin Pharmacol Ther 87: 303-310, 2010.
9. Guignabert C, Izikki M, Tu LI, Li Z, Zadigue P, Barlier-Mur AM, Hanoun N, Rodman D, Hamon M, Adnot S, Eddahibi S. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension. Circ Res 98: 1323-1330, 2006.
10. Hardziyenka M, Campian ME, de Bruin-Bon HA, Michel MC, Tan HL. Sequence of echocardiographic changes during development of right ventricular failure in rat. J Am Soc Echocardiogr 19: 1272-1279, 2006. (Pubitemid 44416169)
11. Hartley CJ, Taffet GE, Reddy AK, Entman ML, Michael LH. Non-invasive cardiovascular phenotyping in mice. ILAR J 43: 147-158, 2002.
12. Hatle L, Angelsen BA, Tromsdal A. Non-invasive estimation of pulmonary artery systolic pressure with Doppler ultrasound. Br Heart J 45: 157-165, 1981.
13. Heiberg E, Wigström L, Carlsson M, Bolger AF, Karlsson M. Time resolved three-dimensional automated segmentation of the left ventricle. Proc IEEE Comput Cardiol 32: 599-602, 2005.
14. Herold V, Parczyk M, Mörchel P, Ziener CH, Klug G, Bauer WR, Rommel E, Jakob PM. In vivo measurement of local aortic pulse-wave velocity in mice with MR microscopy at 17.6 Tesla. Magn Reson Med 61: 1293-1299, 2009.
15. Jones JE, Mendes L, Rudd MA, Russo G, Loscalzo J, Zhang YY. Serial noninvasive assessment of progressive pulmonary hypertension in a rat model. Am J Physiol Heart Circ Physiol 283: H364-H371, 2002. (Pubitemid 34705359)
16. Kato Y, Iwase M, Kanazawa H, Kawata N, Yoshimori Y, Hashimoto K, Yokoi T, Noda A, Takagi K, Koike Y, Nishizawa T, Nishimura M, Yokota M. Progressive development of pulmonary hypertension leading to right ventricular hypertrophy assessed by echocardiography in rats. Exp Anim 52: 285-294, 2003.
17. Kissling G, Ross C, Brandle M. Validity of thermal dilution technique for measurement of cardiac output in rats. Am J Physiol Heart Circ Physiol 265: H1007-H1013, 1993.
18. Kitabatake A, Inoue M, Asao M, Masuyama T, Tanouchi J, Morita T, Mishima M, Uematsu M, Shimazu T, Hori M, Abe H. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation 68: 302-309, 1983. (Pubitemid 13028906)
19. Kohler S, Hiller KH, Jakob PM, Bauer WR, Haase A. Time-resolved flow measurement in the isolated rat heart: characterization of left coronary artery stenosis. Magn Reson Med 50: 449-452, 2003.
20. Koskenvuo JW, Mirsky R, Zhang Y, Angeli FS, Jahn S, Alastalo TP, Schiller NB, Boyle AJ, Chatterjee K, De Marco T, Yeghiazarians Y. A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model. Int J Cardiovasc Imaging 26: 509-518, 2010.
21. Kosturakis D, Goldberg SJ, Allen HD, Loeber C. Doppler echocardiographic prediction of pulmonary arterial hypertension in congenital heart disease. Am J Cardiol 53: 1110-1115, 1984.
22. Levin DL, Hatabu H. MR evaluation of pulmonary blood flow. J Thorac Imaging 19: 241-249, 2004.
23. Ley S, Ley-Zaporozhan J, Kreitner KF, Iliyushenko S, Puderbach M, Hosch W, Wenz H, Schenk JP, Kauczor HU. MR flow measurements for assessment of the pulmonary, systemic and bronchosystemic circulation: impact of different ECG gating methods and breathing schema. Eur J Radiol 61: 124-129, 2007. (Pubitemid 46043416)
24. Mallery JA, Gardin JM, King SW, Ey S, Henry WL. Effects of heart rate and pulmonary artery pressure on Doppler pulmonary artery acceleration time in experimental acute pulmonary hypertension. Chest 100: 470-473, 1991.
25. McMurtry MS, Bonnet S, Wu X, Dyck JR, Haromy A, Hashimoto K, Michelakis ED. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res 95: 830-840, 2004.
26. McMurtry MS, Moudgil R, Hashimoto K, Bonnet S, Michelakis ED, Archer SL. Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 292: L872-L878, 2007.
27. McQuillan BM, Picard MH, Leavitt M, Weyman AE. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 104: 2797-2802, 2001.
28. Moreno-Vinasco L, Gomberg-Maitland M, Maitland ML, Desai AA, Singleton PA, Sammani S, Sam L, Liu Y, Husain AN, Lang RM, Ratain MJ, Lussier YA, Garcia JG. Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension. Physiol Genomics 33: 278-291, 2008.
29. 2+ activation of cardiac myofilaments and the end-systolic pressure-volume relation. J Muscle Res Cell Motil 28: 415-419, 2007.
30. Rey-Parra GJ, Archer SL, Bland RD, Albertine KH, Carlton DP, Cho SC, Kirby B, Haromy A, Eaton F, Wu X, Thebaud B. Blunted hypoxic pulmonary vasoconstriction in experimental neonatal chronic lung disease. Am J Respir Crit Care Med 178: 399-406, 2008.
31. Salyers AK, Rozek LF, Bittner SE, Walsh GM. Simultaneous determination of ventricular function and systemic hemodynamics in the conscious rat. J Pharmacol Methods 19: 267-274, 1988.
32. Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W, Grimminger F. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115: 2811-2821, 2005. (Pubitemid 41434408)
33. Schwenke DO, Pearson JT, Umetani K, Kangawa K, Shirai M. Imaging of the pulmonary circulation in the closed-chest rat using synchrotron radiation microangiography. J Appl Physiol 102: 787-793, 2007. (Pubitemid 46220912)
34. Shapiro SM, Oudiz RJ, Cao T, Romano MA, Beckmann XJ, Georgiou D, Mandayam S, Ginzton LE, Brundage BH. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am Coll Cardiol 30: 343-349, 1997.
35. Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol 297: L1013-L1032, 2009.
36. Turkevich D, Groves BM, Micco A, Trapp JA, Reeves JT. Early partial systolic closure of the pulmonic valve relates to severity of pulmonary hypertension. Am Heart J 115: 409-418, 1988.
37. Vachiery JL, Brimioulle S, Crasset V, Naeije R. False-positive diagnosis of pulmonary hypertension by Doppler echocardiography. Eur Respir J 12: 1476-1478, 1998. (Pubitemid 29011449)
38. van Wolferen SA, Marcus JT, Boonstra A, Marques KM, Bronzwaer JG, Spreeuwenberg MD, Postmus PE, Vonk-Noordegraaf A. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 28: 1250-1257, 2007.
39. West J, Fagan K, Steudel W, Fouty B, Lane K, Harral J, Hoedt-Miller M, Tada Y, Ozimek J, Tuder R, Rodman DM. Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ Res 94: 1109-1114, 2004.
40. Wise RG, Al-Shafei AI, Carpenter TA, Hall LD, Huang CL. Simultaneous measurement of blood and myocardial velocity in the rat heart by phase contrast MRI using sparse q-space sampling. J Magn Reson Imaging 22: 614-627, 2005.
41. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 70: 657-662, 1984. (Pubitemid 14020664)